{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:20:37Z","timestamp":1787631637655,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bcp.2024.116169","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T03:35:26Z","timestamp":1711510526000},"page":"116169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Sorafenib reduces the production of epoxyeicosatrienoic acids and leads to cardiac injury by inhibiting CYP2J in rats"],"prefix":"10.1016","volume":"223","author":[{"given":"Yanfang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenmeizi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junze","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8079-8638","authenticated-orcid":false,"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"38","key":"10.1016\/j.bcp.2024.116169_b0005","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1093\/eurheartj\/ehab362","article-title":"Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study","volume":"42","author":"Salem","year":"2021","journal-title":"Eur Heart J."},{"issue":"11","key":"10.1016\/j.bcp.2024.116169_b0010","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.7150\/thno.54822","article-title":"Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma","volume":"11","author":"Kong","year":"2021","journal-title":"Theranostics."},{"issue":"4","key":"10.1016\/j.bcp.2024.116169_b0015","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1016\/j.bcp.2024.116169_b0020","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/aps.2017.5","article-title":"New knowledge of the mechanisms of sorafenib resistance in liver cancer","volume":"38","author":"Zhu","year":"2017","journal-title":"Acta Pharmacol Sin."},{"issue":"5","key":"10.1016\/j.bcp.2024.116169_b0025","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/ijcp.12352","article-title":"GIDEON (global investigation of therapeutic decisions in hepatocellular carcinoma and its treatment with sorafenib): second interim analysis","volume":"68","author":"Lencioni","year":"2014","journal-title":"Int J Clin Pract."},{"issue":"4","key":"10.1016\/j.bcp.2024.116169_b0030","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.3390\/ijms23042282","article-title":"Mitochondrial toxicity associated with imatinib and sorafenib in isolated rat Heart fibers and the Cardiomyoblast H9c2 cell line","volume":"23","author":"Bouitbir","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"32","key":"10.1016\/j.bcp.2024.116169_b0035","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1200\/JCO.2007.15.6331","article-title":"Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma","volume":"26","author":"Schmidinger","year":"2008","journal-title":"J Clin Oncol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116169_b0040","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.3390\/ijms23052815","article-title":"Cardiotoxicity induced by protein kinase inhibitors in patients with cancer","volume":"23","author":"Grela-Wojewoda","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"19","key":"10.1016\/j.bcp.2024.116169_b0045","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.3390\/ijms20194712","article-title":"Drug-induced hypertension caused by multikinase inhibitors (sorafenib, sunitinib, lenvatinib and axitinib) in renal cell Carcinoma treatment","volume":"20","author":"B\u00e6k M\u00f8ller","year":"2019","journal-title":"Int J Mol Sci."},{"issue":"4","key":"10.1016\/j.bcp.2024.116169_b0050","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/cancers11040571","article-title":"Chronic treatment with multi-kinase inhibitors causes differential toxicities on skeletal and Cardiac muscles","volume":"11","author":"Huot","year":"2019","journal-title":"Cancers (basel)."},{"issue":"12","key":"10.1016\/j.bcp.2024.116169_b0055","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/14779072.2019.1704626","article-title":"Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies","volume":"17","author":"Santoni","year":"2019","journal-title":"Expert Rev Cardiovasc Ther."},{"issue":"2","key":"10.1016\/j.bcp.2024.116169_b0060","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/bcpt.13318","article-title":"Cardiotoxicity of sorafenib is mediated through elevation of ROS level and CaMKII activity and dysregulation of calcium homoeostasis","volume":"126","author":"Ma","year":"2020","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"10.1016\/j.bcp.2024.116169_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.107017","article-title":"Sorafenib induces cardiotoxicity through RBM20-mediated alternative splicing of sarcomeric and mitochondrial genes","volume":"198","author":"Liu","year":"2023","journal-title":"Pharmacol Res."},{"issue":"12","key":"10.1016\/j.bcp.2024.116169_b0070","doi-asserted-by":"crossref","first-page":"e15666","DOI":"10.1371\/journal.pone.0015666","article-title":"Metabolic activity and mRNA levels of human cardiac CYP450s involved in drug metabolism","volume":"5","author":"Michaud","year":"2010","journal-title":"PLoS One."},{"issue":"8","key":"10.1016\/j.bcp.2024.116169_b0075","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.addr.2011.03.006","article-title":"The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases","volume":"63","author":"Xu","year":"2011","journal-title":"Adv Drug Deliv Rev."},{"issue":"8","key":"10.1016\/j.bcp.2024.116169_b0080","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1124\/dmd.117.078964","article-title":"Cytochrome P450 2J2: potential role in drug metabolism and Cardiotoxicity","volume":"46","author":"Solanki","year":"2018","journal-title":"Drug Metab Dispos."},{"issue":"5","key":"10.1016\/j.bcp.2024.116169_b0085","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1124\/dmd.111.043505","article-title":"Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity","volume":"40","author":"Lee","year":"2012","journal-title":"Drug Metab Dispos."},{"issue":"51","key":"10.1016\/j.bcp.2024.116169_b0090","doi-asserted-by":"crossref","first-page":"6700","DOI":"10.1021\/acs.biochem.7b01025","article-title":"Arachidonic acid metabolism by human Cardiovascular CYP2J2 is modulated by doxorubicin","volume":"56","author":"Arnold","year":"2017","journal-title":"Biochemistry."},{"key":"10.1016\/j.bcp.2024.116169_b0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bcp.2016.03.005","article-title":"Multiple modes of inhibition of human cytochrome P450 2J2 by dronedarone, amiodarone and their active metabolites","volume":"107","author":"Karkhanis","year":"2016","journal-title":"Biochem Pharmacol."},{"key":"10.1016\/j.bcp.2024.116169_b0100","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bcp.2017.09.012","article-title":"Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids","volume":"146","author":"Karkhanis","year":"2017","journal-title":"Biochem Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2024.116169_b0105","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1124\/dmd.122.000928","article-title":"Inhibition of cytochrome P450 2J2-mediated metabolism of Rivaroxaban and Arachidonic acid by ibrutinib and Osimertinib","volume":"50","author":"Wang","year":"2022","journal-title":"Drug Metab Dispos."},{"issue":"11","key":"10.1016\/j.bcp.2024.116169_b0110","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1124\/dmd.120.000114","article-title":"Generation and Characterization of cytochrome P450 2J3\/10 CRISPR\/Cas9 knockout rat model","volume":"48","author":"Lu","year":"2020","journal-title":"Drug Metab Dispos."},{"key":"10.1016\/j.bcp.2024.116169_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116610","article-title":"CYP2J deficiency leads to cardiac injury and presents dual regulatory effects on cardiac function in rats","volume":"473","author":"Zhang","year":"2023","journal-title":"Toxicol Appl Pharmacol."},{"key":"10.1016\/j.bcp.2024.116169_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153779","article-title":"Gansui-banxia decoction extraction inhibits MDSCs accumulation via AKT \/STAT3\/ERK signaling pathways to regulate antitumor immunity in C57bl\/6 mice","volume":"93","author":"Feng","year":"2021","journal-title":"Phytomedicine."},{"issue":"6","key":"10.1016\/j.bcp.2024.116169_b0125","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00280-020-04075-3","article-title":"In vivo assessment of the drug interaction between sorafenib and paracetamol in rats","volume":"85","author":"Karbownik","year":"2020","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1016\/j.bcp.2024.116169_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113763","article-title":"Investigation of the content differences of arachidonic acid metabolites in a mouse model of breast cancer by using LC-MS\/MS","volume":"194","author":"Chen","year":"2021","journal-title":"J Pharm Biomed Anal."},{"issue":"5","key":"10.1016\/j.bcp.2024.116169_b0135","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3390\/ijms21051875","article-title":"Assessment of the effect of sorafenib on Omega-6 and Omega-3 epoxyeicosanoid formation in patients with Hepatocellular Carcinoma","volume":"21","author":"Leineweber","year":"2020","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.bcp.2024.116169_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121122","article-title":"Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs","volume":"310","author":"Zhang","year":"2022","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.bcp.2024.116169_b0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10741-016-9530-2","article-title":"Mitochondrial dynamics and cell death in heart failure","volume":"21","author":"Mar\u00edn-Garc\u00eda","year":"2016","journal-title":"Heart Fail Rev."},{"issue":"2","key":"10.1016\/j.bcp.2024.116169_b0150","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/1440-1681.12863","article-title":"Age-dependent electrocardiographic changes in pgc-1\u03b2 deficient murine hearts","volume":"45","author":"Ahmad","year":"2018","journal-title":"Clin Exp Pharmacol Physiol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116169_b0155","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/CIRCRESAHA.110.223818","article-title":"PGC-1 coactivators in cardiac development and disease","volume":"107","author":"Rowe","year":"2010","journal-title":"Circ Res."},{"issue":"2","key":"10.1016\/j.bcp.2024.116169_b0160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jphs.2018.09.010","article-title":"Improved endogenous epoxyeicosatrienoic acid production mends heart function via increased PGC 1\u03b1-mitochondrial functions in metabolic syndrome","volume":"138","author":"Liu","year":"2018","journal-title":"J Pharmacol Sci."},{"key":"10.1016\/j.bcp.2024.116169_b0165","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3389\/fphys.2018.01094","article-title":"Acetylation of mitochondrial proteins in the Heart: the role of SIRT3","volume":"9","author":"Parodi-Rull\u00e1n","year":"2018","journal-title":"Front Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116169_b0170","first-page":"233","article-title":"CYP-450 epoxygenase derived epoxyeicosatrienoic acid contribute to reversal of Heart failure in obesity-induced diabetic Cardiomyopathy via PGC-1\u03b1 activation","volume":"7","author":"Singh","year":"2018","journal-title":"Cardiovasc Pharm Open Access."},{"issue":"5","key":"10.1016\/j.bcp.2024.116169_b0175","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacep.2018.03.006","article-title":"Clinical Spectrum of SCN5A mutations: long QT syndrome, brugada syndrome, and Cardiomyopathy","volume":"4","author":"Wilde","year":"2018","journal-title":"JACC Clin Electrophysiol."},{"issue":"9","key":"10.1016\/j.bcp.2024.116169_b0180","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1253\/circj.CJ-13-0294","article-title":"Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy","volume":"77","author":"N\u00fa\u00f1ez","year":"2013","journal-title":"Circ J."},{"issue":"10","key":"10.1016\/j.bcp.2024.116169_b0185","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/1535370218777972","article-title":"Dysfunctional Nav1.5 channels due to SCN5A mutations","volume":"243","author":"Han","year":"2018","journal-title":"Exp Biol Med (maywood)."},{"key":"10.1016\/j.bcp.2024.116169_b0190","doi-asserted-by":"crossref","unstructured":"Miyamoto L. Molecular Pathogenesis of Familial Wolff-Parkinson-White Syndrome. J. Med. Invest. 2018;65(1.2):1-8.","DOI":"10.2152\/jmi.65.1"},{"issue":"7","key":"10.1016\/j.bcp.2024.116169_b0195","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic Cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res."},{"issue":"1","key":"10.1016\/j.bcp.2024.116169_b0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1672-0229(11)60029-6","article-title":"The transcript-centric mutations in human genomes","volume":"10","author":"Cui","year":"2012","journal-title":"Genom. Proteom. Bioinformat."},{"key":"10.1016\/j.bcp.2024.116169_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107863","article-title":"The natriuretic peptide system in heart failure: diagnostic and therapeutic implications","volume":"227","author":"Kuwahara","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.bcp.2024.116169_b0210","doi-asserted-by":"crossref","first-page":"194","DOI":"10.21037\/atm.2016.05.19","article-title":"An historical approach to the diagnostic biomarkers of acute coronary syndrome","volume":"4","author":"Danese","year":"2016","journal-title":"Ann. Transl Med."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:23:34Z","timestamp":1728951814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224001527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":42,"alternative-id":["S0006295224001527"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116169","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sorafenib reduces the production of epoxyeicosatrienoic acids and leads to cardiac injury by inhibiting CYP2J in rats","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116169","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116169"}}